NCT05248230Phase 2Recruiting

4D-710 in Adult Patients With Cystic Fibrosis

Study sponsor: 4D Molecular Therapeutics

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2027-06Estimated
Enrollment · participants30Estimated
Source updated2026-07-06Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 2 fields changed

Planned enrollment decreased by 10 participants

Before: 40 participants (planned). After: 30 participants (planned).

Primary completion date changed

Before: Dec 2026. After: Jun 2027.

Check registry source

· 1 field changed

Phase changed

Before: PHASE1, PHASE2. After: PHASE2.

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview